Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
China Launch Startup Orienspace Raises Nearly USD 60 Mn in Series A Round
Facing the explosive demand of various satellite networks, Orienspace innovatively builds the “Gravity” series of medium-and-large-sized commercial launch vehicles, achieving the economies of scale
Yesterday 07:50 PM
Smart Mining Truck Maker Easymove Raises Tens of Mns of CNY in Angel Round
With the development of new energy industry, huge opportunities existed in vehicle electrification under different mobile scenarios, and construction machinery is one of the largest potential markets
Yesterday 02:29 PM
New Normal, New Policies: A Focus on Healthcare in Two Sessions
The week-long Chinese virtual ‘Two Sessions’ meeting closed on May 28. The hovering pandemic has made the healthcare topic a highlight for the 2020 third session of the 13th National People’s Congress.
Jun 03, 2020 03:06 PM